RESEARCHER PROFILE
David E. Koren
← Back to Temple University Health System
D
Temple University Health System
David E. Koren works in HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment, HIV Research and Treatment, Pharmacy and Medical Practices, Hepatitis C virus research. Recorded institutional associations include Temple University Hospital, Temple University Health System.
38Publications
602Citations
13H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019
2020 · 214 citationsHIV Pre-Exposure Prophylaxis and Women: Survey of the Knowledge, Attitudes, and Beliefs in an Urban Obstetrics/Gynecology Clinic
2018 · 66 citationsThe Pharmacist's Expanding Role in HIV Pre-Exposure Prophylaxis
2019 · 58 citationsExpanding Hepatitis C Virus Care and Cure: National Experience Using a Clinical Pharmacist–Driven Model
2019 · 34 citationsA Call to Action: The Role of Antiretroviral Stewardship in Inpatient Practice, a Joint Policy Paper of the Infectious Diseases Society of America, HIV Medicine Association, and American Academy of HIV Medicine
2019 · 34 citationsHIV: how to manage heavily treatment-experienced patients
2022 · 24 citationsLenacapavir: A Novel Long-Acting Capsid Inhibitor for HIV
2023 · 23 citationsIbalizumab
2018 · 22 citationsImpact of an Antiretroviral Stewardship Team on the Care of Patients With Human Immunodeficiency Virus Infection Admitted to an Academic Medical Center
2019 · 20 citationsFostemsavir: A Novel Attachment Inhibitor for Patients With Multidrug-Resistant HIV-1 Infection
2020 · 18 citationsHepatitis C Update and Expanding the Role of Primary Care
2019 · 17 citationsPerceptions of Long-Acting Injectable Antiretroviral Treatment Regimens in a United States Urban Academic Medical Center
2020 · 16 citationsConsensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV ‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists
2024 · 14 citationsPredicting Treatment Failure for Initiators of Hepatitis C Virus Treatment in the era of Direct-Acting Antiviral Therapy
2020 · 11 citationsConsensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists: An executive summary
2024 · 9 citationsCrushing and Splitting Direct-Acting Antivirals for Hepatitis C Virus Treatment: A Case Series and Literature Review
2021 · 8 citationsClinical outcomes after IL-6 blockade in patients with COVID-19 and HIV: a case series
2022 · 5 citations2498. Perceptions of Injectable Antiretrovirals in an Urban HIV Clinic
2019 · 3 citationsImplementation Determinants of HIV Testing and Pre-Exposure Prophylaxis in Community Pharmacies in Philadelphia, PA
2025 · 2 citationsLenacapavir: A Twice-Yearly Injectable for HIV Preexposure Prophylaxis
2025 · 2 citationsClasses of Antiretrovirals
2019 · 1 citationsPhysician Survey Results: Clinical Practice Training Is Needed to Improve Ob/Gyn PrEP Adoption [02A]
2020 · 1 citations1040. Real-World Implementation of Dolutegravir-Lamivudine to Achieve and Maintain HIV-1 Viral Suppression at an Academic Medical Center
2020 · 1 citations592. Determining the Impact of an Antiretroviral Stewardship Team on the Care of HIV-Infected Patients Admitted to an Academic Research Institution
2018 · 0 citationsPIN93 PREDICTION MODEL OF TREATMENT FAILURE AMONG CHRONIC HEPATITIS C PATIENTS AT FOUR UNITED STATES INSTITUTIONS
2019 · 0 citations
